首页|期刊导航|吉林中医药|基于"虚损瘀毒"理论与肠道菌群相关性探讨阿尔茨海默病的防治

基于"虚损瘀毒"理论与肠道菌群相关性探讨阿尔茨海默病的防治OA

Prevention and treatment of Alzheimer's disease based on the correlation between the theory of"deficiency,stasis and toxin"and gut microbiota

中文摘要英文摘要

阿尔茨海默病(AD)属于神经退行性疾病,病理机制复杂且目前缺乏有效治疗手段.本文基于中医"虚损瘀毒"理论,结合肠道菌群研究进展,探讨AD防治策略.现有研究表明,脾肾虚损为AD发病之本,痰瘀浊毒壅阻脑络为标实,二者形成"虚-瘀-毒"恶性循环;肠道菌群失调可通过破坏肠-脑轴稳态,加剧神经炎症及代谢紊乱,与AD病理进程密切相关.中药干预可通过调节肠道菌群结构、修复肠黏膜屏障、抑制炎症因子释放等途径,可改善AD模型动物认知功能.本研究为中西医结合防治AD提供理论依据,并揭示中医药通过肠-脑轴多靶点调控之科学内涵,为AD精准治疗开辟新路径.

Alzheimer's disease(AD),a neurodegenerative disorder,is characterized by a complex pathogenesis and a lack of effective treatment.This study explores strategies for the prevention and treatment of AD based on the traditional Chinese medicine(TCM)theory of"deficiency,stasis and toxin",combined with the modern research on gut microbiome omics.It is found that spleen and kidney deficiency constitutes the root cause of AD,while phlegm,stasis,turbidity,and toxins obstructing the cerebral meridians represents its manifestations,and the two factors form a vicious cycle of"deficiency-stasis-toxin".Dysbiosis of the gut microbiota is closely associated with the pathological progression of AD by disrupting the gut-brain axis homeostasis,thereby exacerbating neuroinflammation and metabolic disorders.TCM interventions(such as Danggui Shaoyao San and tonifying formulas)may significantly improve the cognitive function in AD animal models by regulating the gut microbiota composition,repairing the intestinal mucosal barrier,and inhibiting the release of inflammatory factors.This study is aimed at providing a theoretical basis for the integrated prevention and treatment of AD using both western and traditional Chinese medicine,revealing the scientific rationale behind TCM's multi-target regulation via the"gut-brain axis",and opening new pathways for the precision treatment of AD.

林菁菁;于顾然

南京中医药大学附属医院,南京 210029南京中医药大学附属医院,南京 210029

医药卫生

阿尔茨海默病"虚损瘀毒"理论肠道菌群

Alzheimer's diseasedeficiency-stasis-toxin theorygut microbiota

《吉林中医药》 2026 (9)

1081-1087,7

国家重点研发计划(2022YFC3501403)

10.13463/j.cnki.jlzyy.2026.09.001

评论